Stability failure with limited batches during lifecycle management: CAPA with limited data sets
Recognizing the symptoms of a stability failure is paramount for swift action. Common signals to watch for include:Click to read the full article.
Orphan Drugs
Method variability OOS during regulatory review: FDA/EMA communication strategy
Identifying symptoms or signals of method variability OOS starts with vigilant monitoring during the analytical phase of product development and quality control. Common indicators include:Click to read the full article.
Stability failure with limited batches during inspection readiness: CAPA with limited data sets
When a stability failure occurs, the first step is identifying the symptoms or signals that indicate an issue. Key symptoms may include:Click to read the full article.
Stability failure with limited batches during small-batch manufacturing: risk-based GMP justification
Addressing Stability Failures in Limited Batches During Small-Batch Manufacturing Stability failures in pharmaceutical products, particularly with limited batches during small-batch manufacturing, pose significant challenges for quality assurance and regulatory compliance.…
Stability failure with limited batches during inspection readiness: risk-based GMP justification
Identifying symptoms of stability failure is often the first indication that a problem exists. Common signals may include:Click to read the full article.
Specification justification gap during lifecycle management: risk-based GMP justification
Identifying symptoms or signals indicative of a specification justification gap is critical for mitigation. Symptoms may include:Click to read the full article.
Specification justification gap during lifecycle management: FDA/EMA communication strategy
Identifying early symptoms or signals of a specification justification gap is essential. Some common indicators include:Click to read the full article.
Method variability OOS during small-batch manufacturing: risk-based GMP justification
The first step in managing OOS incidents is recognizing the symptoms. Symptoms can manifest in several ways across both the manufacturing floor and laboratory setting:Click to read the full article.